May 6, 2019

Trump hits all-time high approval rating in Gallup poll

Photo: Drew Angerer/Getty Images

President Trump hit a 46% approval rating in Gallup's tracking poll, the highest thus far in his presidency.

The big picture: Gallup notes that Trump's bump is likely due to good economic news — higher than expected GDP and jobs growth — and the administration's interpretation of the Mueller report, which the president erroneously claimed exonerated him of allegations of collusion and obstruction.

By the numbers: The president managed to notch a 12% approval rating from Democrats — substantially higher than his all-time low of 4% just a few months ago.

  • His approval rating with Republicans also flirted with an all-time high, sitting at 91% — just short of the 92% reached late last year.

Yes, but: The poll ended on April 30, meaning that it does not include the most recent flareup between Attorney General Bill Barr and the House Judiciary Committee, which could be viewed negatively by the public.

  • And it's of course worth nothing that Trump's disapproval rating from Gallup remains at 50%, meaning his net approval remains underwater by 4 points.

Go deeper: Trump's 2020 map from hell

Go deeper

Pandemic forces startups to shift gears

Illustration: Eniola Odetunde/Axios

Spaces CEO Brad Herman had an early warning about COVID-19 because his startup supplies VR attractions to a number of theme parks in China. Realizing that the business he spent the last few years building was going to evaporate, Herman quickly found a new way to apply his team's know-how: helping companies host Zoom teleconferences in VR.

Why it matters: Many startups are rethinking the viability of their core businesses in the wake of the coronavirus. Spaces' move is one of many such pivots likely to crop up in the coming months.

International coronavirus treatment trial uses AI to speed results

Hydroxychloroquine is one of the drugs that will be included in the trial. Photo: John Philips/Getty Images

The first hospital network in the U.S. has joined an international clinical trial using artificial intelligence to help determine which treatments for patients with the novel coronavirus are most effective on an on-going basis.

Why it matters: In the midst of a pandemic, scientists face dueling needs: to find treatments quickly and to ensure they are safe and effective. By using this new type of adaptive platform, doctors hope to collect clinical data that will help more quickly determine what actually works.

We can't just flip the switch on the coronavirus

Illustration: Sarah Grillo/Axios

It feels like some big, terrible switch got flipped when the coronavirus upended our lives — so it’s natural to want to simply flip it back. But that is not how the return to normalcy will go.

The big picture: Even as the number of illnesses and deaths in the U.S. start to fall, and we start to think about leaving the house again, the way forward will likely be slow and uneven. This may feel like it all happened suddenly, but it won't end that way.